These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1163 related articles for article (PubMed ID: 69026)

  • 1. Synthesis and antitumor activity of dihydro-5-azacytidine, a hydrolytically stable analogue of 5-azacytidine.
    Beisler JA; Abbasi MM; Kelley JA; Driscoll JS
    J Med Chem; 1977 Jun; 20(6):806-12. PubMed ID: 69026
    [No Abstract]   [Full Text] [Related]  

  • 2. Antitumor activity of pyrazofurin in combination with 5-azacytidine against murine P388 and L1210 leukemias and colon carcinoma 26.
    Chiuten DF; Muggia FM; Johnson RK
    Cancer Treat Rep; 1979; 63(11-12):1857-62. PubMed ID: 93512
    [No Abstract]   [Full Text] [Related]  

  • 3. Synthesis and antitumor activity of 5-azacytosine arabinoside.
    Beisler JA; Abbasi MM; Driscoll JS
    J Med Chem; 1979 Oct; 22(10):1230-4. PubMed ID: 92567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prodrug analogues of the antitumor alkaloid camptothecin.
    Adamovics JA; Hutchinson CR
    J Med Chem; 1979 Mar; 22(3):310-4. PubMed ID: 423214
    [No Abstract]   [Full Text] [Related]  

  • 5. Dihydro-5-azacytidine hydrochloride, a biologically active and chemically stable analog of 5-azacytidine.
    Beisler JA; Abbasi MM; Driscoll JS
    Cancer Treat Rep; 1976 Nov; 60(11):1671-4. PubMed ID: 66095
    [No Abstract]   [Full Text] [Related]  

  • 6. Potential central nervous system antitumor agents. Aziridinylbenzoquinones. 1.
    Khan AH; Driscoll JS
    J Med Chem; 1976 Feb; 19(2):313-7. PubMed ID: 1249812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumour activity of some cyclophosphazenes.
    Labarre JF; Faucher JP; Levy G; Sournies F; Cros S; François G
    Eur J Cancer (1965); 1979 May; 15(5):637-43. PubMed ID: 510331
    [No Abstract]   [Full Text] [Related]  

  • 8. New designs in inorganic ring systems as anticancer drugs. Antitumor activity of the aziridino (ethylene-imino) derivatives (NPAz2)2NSOX with X = F, Az, Ph.
    Labarre JF; Sournies F; Cros S; François G; van de Grampel JC; van der Huizen AA
    Cancer Lett; 1981 Apr; 12(3):245-50. PubMed ID: 7260894
    [No Abstract]   [Full Text] [Related]  

  • 9. The synthesis and antitumor activity of arabinosyl-5-azacytosine.
    Beisler JA; Abbasi MM; Driscoll JS
    Biochem Pharmacol; 1977 Dec; 26(24):2469-72. PubMed ID: 74254
    [No Abstract]   [Full Text] [Related]  

  • 10. Potential central nervous system antitumor agents. Hydantoin derivatives.
    Peng GW; Marquez VE; Driscoll JS
    J Med Chem; 1975 Aug; 18(8):846-9. PubMed ID: 1159704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential CNS antitumor agents VI: aziridinylbenzoquinones III.
    Driscoll JS; Dudeck L; Congleton G; Geran RI
    J Pharm Sci; 1979 Feb; 68(2):185-8. PubMed ID: 423089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active antitumor components in a decomposed amino sugar I: Effect of sugar structure on activity.
    Khan AH; Driscoll JS
    J Pharm Sci; 1975 Feb; 64(2):295-9. PubMed ID: 1127586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indicine-N-oxide: the antitumor principle of Heliotropium indicum.
    Kugelman M; Liu WC; Axelrod M; McBride TJ; Rao KV
    Lloydia; 1976; 39(2-3):125-8. PubMed ID: 948236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-tumour activity of the extract of Semecarpus anacardium L. nuts in experimental tumor models.
    Chitnis MP; Bhatia KG; Phatak MK; Kesava Rao KV
    Indian J Exp Biol; 1980 Jan; 18(1):6-8. PubMed ID: 7399581
    [No Abstract]   [Full Text] [Related]  

  • 15. Antineoplastic agents. 34. Helenium autumnale L.
    Pettit GR; Budzinski JC; Cragg GM; Brown P; Johnston LD
    J Med Chem; 1974 Sep; 17(9):1013-6. PubMed ID: 4412057
    [No Abstract]   [Full Text] [Related]  

  • 16. Enhancement by tetrahydrouridine (NSC-112907) of the oral activity of 5-azacytidine (NSC-102816) in L1210 leukemic mice.
    Neil GL; Moxley TE; Kuentzel SL; Manak RC; Hanka LJ
    Cancer Chemother Rep; 1975; 59(3):459-65. PubMed ID: 54211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical pharmacology of 5,6-dihydro-5-azacytidine (DHAC) and DNA hypomethylation in tumor (L1210)-bearing mice.
    Powell WC; Avramis VI
    Cancer Chemother Pharmacol; 1988; 21(2):117-21. PubMed ID: 2450689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural modification study of bis(substituted aminoalkylamino)anthraquinones. An evaluation of the relationship of the [2-[(2-hydroxyethyl)amino]ethyl]amino side chain with antineoplastic activity.
    Zee-Cheng RK; Podrebarac EG; Menon CS; Cheng CC
    J Med Chem; 1979 May; 22(5):501-5. PubMed ID: 458801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and antitumor activity of 4-[p-[bis(2-chloroethyl)amino]phenyl]butyrates.
    Roehrig GR; Billman JH; Marcec J; Fritz P; Shea F
    J Pharm Sci; 1980 Oct; 69(10):1232-4. PubMed ID: 7420301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The experimental antitumour properties of three congeners of the acridylmethanesulphonanilide (AMSA) series.
    Cain BF; Atwell GJ
    Eur J Cancer (1965); 1974 Aug; 10(8):539-49. PubMed ID: 4463003
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 59.